Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000354729 | SCV000399962 | likely benign | Malignant Melanoma Susceptibility | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000473808 | SCV000556942 | benign | Melanoma, cutaneous malignant, susceptibility to, 5 | 2024-09-23 | criteria provided, single submitter | clinical testing | |
3billion | RCV000662301 | SCV002521043 | uncertain significance | Tyrosinase-positive oculocutaneous albinism | 2022-05-22 | criteria provided, single submitter | clinical testing | The variant is observed as homozygous in at least two unrelated individuals/adults in the gnomAD v.2.1.1 dataset and therefore considered benign. Same nucleotide change resulting in same amino acid change has been previously reported to be associated with MC1R- related disorder (ClinVar ID: VCV000321430). However, the evidence of pathogenicity is insufficient at this time with conflicting interpretations of pathogenicity. Therefore, this variant is classified as uncertain significanceaccording to the recommendation of ACMG/AMP guideline. |
Department of Pathology and Laboratory Medicine, |
RCV000662301 | SCV006053880 | likely benign | Tyrosinase-positive oculocutaneous albinism | 2020-09-01 | criteria provided, single submitter | research | |
Yale Center for Mendelian Genomics, |
RCV000662301 | SCV000784629 | likely pathogenic | Tyrosinase-positive oculocutaneous albinism | 2015-09-22 | no assertion criteria provided | literature only | |
University of Washington Center for Mendelian Genomics, |
RCV000851262 | SCV000993518 | likely pathogenic | Skin and Hair Hypopigmentation | 2015-09-22 | no assertion criteria provided | research |